S'abonner

Diabetes mellitus is a coronary heart disease risk equivalent for peripheral vascular disease - 18/04/17

Doi : 10.1016/j.ahj.2016.09.002 
Jonathan D. Newman, MD, MPH a, b, , Caron B. Rockman, MD c, Mikhail Kosiborod, MD d, Yu Guo, MA e, Hua Zhong, PhD e, Howard S. Weintraub, MD a, b, Arthur Z. Schwartzbard, MD a, b, Mark A. Adelman, MD c, Jeffrey S. Berger, MD, MS a, b,
a Division of Cardiology, Department of Medicine, New York University Medical Center, New York, NY 
b Center for the Prevention of Cardiovascular Disease, New York University Medical Center, New York, NY 
c Division of Vascular Surgery, Department of Surgery, New York University Medical Center, New York, NY 
d Saint Luke's Mid America Heart Institute and University of Missouri–Kansas City, Kansas City, MO 
e Division of Biostatistics, Department of Population Health, New York University Medical Center, New York, NY 

Reprint requests: Jonathan D. Newman, MD, MPH, and Jeffrey S. Berger, MD, MS, Division of Cardiology and The Center for the Prevention of Cardiovascular Disease, New York University School of Medicine, 227 E 30th St, TRB Room 853, New York, NY 10016.Division of Cardiology and The Center for the Prevention of Cardiovascular DiseaseNew York University School of Medicine227 E 30th St, TRB Room 853New YorkNY10016

Background

Diabetes mellitus (diabetes) is associated with significantly increased risk of peripheral vascular disease. Diabetes is classified as a coronary heart disease (CHD) risk equivalent, but it is unknown whether diabetes is a CHD risk equivalent for peripheral vascular disease. The objective was to evaluate the odds of peripheral arterial disease (PAD) or carotid artery stenosis (CAS) among participants with diabetes, CHD, or both, compared with participants without diabetes or CHD, in a nationwide vascular screening database. We hypothesized that diabetes and CHD would confer similar odds of PAD and CAS.

Methods

A cross-sectional analysis of all eligible Life Line Screening Inc participants age 30 to 90 years with ankle brachial indices for PAD (ankle brachial index <0.9 in either leg) and carotid artery duplex ultrasonographic imaging for CAS (internal CAS ≥50%) was performed (N=3,522,890).

Results

Diabetes and CHD were present in 372,330 (10.7%) and 182,760 (5.8%) of participants, respectively; PAD and CAS were present in 155,000 (4.4%) and 130,347 (3.7%) of participants. After multivariable adjustment, PAD odds were 1.56 (95% CI 1.54-1.59) and 1.69 (95% CI 1.65-1.73) for participants with diabetes or CHD, respectively. Participants with both diabetes and CHD had 2.75-fold increased odds of PAD (95% CI 2.66-2.85). Findings were similar for CAS; compared with no diabetes or CHD, CAS odds increased for participants with diabetes alone (1.53, 95% CI 1.50-1.56), CHD alone (1.72, 95% CI 1.68-1.76), and both diabetes and CHD (2.57, 95% CI 2.49-2.66). Findings were consistent for women and men.

Conclusion

In a large database of more than 3.5 million self-referred participants, diabetes was a CHD risk equivalent for PAD and CAS, and participants with comorbid diabetes and CHD had an especially robust association with PAD and CAS. Counseling regarding screening and prevention of peripheral vascular disease may be useful for patients with diabetes.

Le texte complet de cet article est disponible en PDF.

Graphical abstract

Peripheral vascular disease risk for diabetes and CHD.



Image 3

Le texte complet de cet article est disponible en PDF.

Plan


 Financial support: Dr Newman was partially funded by the National Heart, Lung, and Blood Institute of the National Institutes of Health (K23HL125991) and American Heart Association Mentored Clinical and Population Research Award (15MCPRP24480132). Dr Berger was partially funded by the National Heart, Lung, and Blood Institute of the National Institutes of Health (HL114978). Funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the article.
 Relationships with industry: none.
 Deepak L. Bhatt, MD, MPH served as guest editor for this article.


© 2016  Elsevier Inc. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 184

P. 114-120 - février 2017 Retour au numéro
Article précédent Article précédent
  • Left bundle-branch block in patients with acute myocardial infarction: Presentation, treatment, and trends in outcome from 1997 to 2016 in routine clinical practice
  • Paul Erne, Juan F. Iglesias, Philip Urban, Franz R. Eberli, Hans Rickli, René Simon, Thomas A. Fischer, Dragana Radovanovic
| Article suivant Article suivant
  • An age- and sex-specific gene expression score is associated with revascularization and coronary artery disease: Insights from the Prospective Multicenter Imaging Study for Evaluation of Chest Pain (PROMISE) trial
  • Deepak Voora, Adrian Coles, Kerry L. Lee, Udo Hoffmann, James A. Wingrove, Brian Rhees, Lin Huang, Susan E. Daniels, Mark Monane, Steven Rosenberg, Svati H. Shah, William E. Kraus, Geoffrey S. Ginsburg, Pamela S. Douglas

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.